RNAZ TransCode Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 14, 2026
$1,57
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$1,52rendah 52m
$20,99tinggi 52m
Kapitalisasi Pasar (MRQ)
$2M
P/E
-0.1
EPS
$-52.59
lencana Anda
Rentang 52M
$2–$21
Peringkat Analis
BUY
Target Harga
·
P/E
-0.1
ROE
·
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
RNAZ Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$1.57
Kapitalisasi Pasar (MRQ)
$2M
P/E
-0.1
EPS
$-52.59
Rentang 52M
$2–$21
RNAZ Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 15 Mei 2025 | 1-for-28 | Terbalik |
| 4 Des. 2024 | 1-for-33 | Terbalik |
| 16 Jan. 2024 | 1-for-40 | Terbalik |
| 23 Mei 2023 | 1-for-20 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-52.592020-12-31 → 2025-12-31
Arus Kas Bebas·2021-12-31 → 2023-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | RNAZ | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -0.1rata-rata 5T ≈-463689.3 | ≈-463689.3 | · | · | |
| P/B (MRQ) | -0.1rata-rata 5T ≈1060643.4 | ≈1060643.4 | · | · | |
| Harga / Nilai Buku Berwujud (MRQ) | -0.0rata-rata 5T ≈1060643.4 | ≈1060643.4 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | RNAZ | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 2.0rata-rata 5T ≈4.0 | ≈4.0 | 2.4 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
1.6%
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 31 Des. 2024 | $-150.64 | $-91.68 | -64.3% | |
| 30 Sep. 2024 | $-147.84 | $-461.82 | 68.0% | |
| 30 Juni 2024 | $-665.28 | $-546.64 | -21.7% | |
| 31 Maret 2024 | $-498.96 | $-659.74 | 24.4% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $10M | $12M | $10M | $3M | $284.5K | |
| SG&A Expense | $6M | $6M | $7M | $8M | $3M | $442.1K | |
| Operating Expenses | $28M | $16M | $19M | $19M | $6M | $726.6K | |
| Operating Income | $-28M | $-16M | $-19M | $-19M | $-6M | $-726.6K | |
| Interest Expense | · | $26.8K | $55.9K | $32.0K | $95.1K | $394.6K | |
| Interest Income | $79.2K | $684 | $5.3K | $20.4K | $664 | $136 | |
| Other Non-op | $-6M | $-1M | $872.4K | $1M | $-692.3K | $-2M | |
| Pretax Income | $-34M | $-17M | · | · | · | · | |
| Income Tax | $226.1K | $0 | $0 | $0 | $53.1K | $0 | |
| Net Income | $-35M | $-17M | $-19M | $-18M | $-7M | $-2M | |
| EPS (Basic) | $-52.59 | $-1336.63 | $-3419.01 | $-1082.79 | $-0.81 | $-0.51 | |
| EPS (Diluted) | $-52.59 | $-1336.63 | $-3419.01 | $-1082.79 | $-0.81 | $-0.51 | |
| Shares (Basic) | 689,713 | 12,558 | 5,424 | 16,222 | 8,425,880 | 4,636,216 | |
| Shares (Diluted) | 689,713 | 12,558 | 5,424 | 16,222 | 8,425,880 | 4,636,216 | |
| EBITDA | · | · | $-19M | $-19M | $-6M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $6M | $3M | $5M | $21M | $828.0K | |
| Prepaid Expense | $919.4K | $1M | $2M | $2M | $2M | $3.2K | |
| Current Assets | $22M | $7M | $4M | $7M | $23M | $831.2K | |
| PP&E (Net) | $370.7K | $51.6K | $120.7K | $208.6K | $206.3K | · | |
| PP&E (Gross) | $757.9K | $362.4K | $384.1K | $348.4K | $247.5K | · | |
| Accum. Depreciation | $387.3K | $310.8K | $263.3K | $139.9K | $41.3K | · | |
| Goodwill | $26M | · | · | · | · | · | |
| Intangibles | $114M | · | · | · | · | · | |
| Total Assets | $162M | $7M | $5M | $8M | $23M | $1M | |
| Accounts Payable | $3M | $3M | $3M | $4M | $3M | $369.2K | |
| Current Liabilities | $3M | $3M | $3M | $4M | $3M | $404.9K | |
| Capital Leases | · | · | $38.3K | · | · | · | |
| Deferred Tax | $226.1K | · | · | · | · | · | |
| Total Liabilities | $11M | $9M | $4M | $4M | $3M | $4M | |
| Common Stock | $92 | $4 | $2 | $2 | $1.3K | $464 | |
| Paid-in Capital | $108M | $61M | $48M | $31M | $31M | $65.9K | |
| Retained Earnings | $-98M | $-63M | $-46M | $-28M | $-10M | $-3M | |
| Stockholders' Equity | $10M | $-2M | $2M | $3M | $20M | $-3M | |
| Liabilities + Equity | $162M | $7M | $5M | $8M | $23M | $1M | |
| Shares Outstanding | 916,968 | 36,753 | 19,014 | 16,222 | 12,904,574 | 4,636,216 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $13.4K | $90.9K | $123.5K | $98.6K | $42.5K | $0 | |
| Stock-based Comp | $485.4K | $2M | $1M | $395.3K | $186.0K | $45.4K | |
| Deferred Tax | $226.1K | · | · | · | · | · | |
| Other Non-cash | · | · | $-688.8K | $1M | $1M | · | |
| Operating Cash Flow | $-20M | $-13M | $-18M | $-16M | $-5M | $-493.0K | |
| CapEx | $6.7K | $21.8K | $35.6K | $100.9K | $254.8K | · | |
| Investing Cash Flow | $-4.4K | $-21.8K | $-35.6K | $-100.9K | $-251.8K | · | |
| Stock Issued | $9M | $16M | $16M | $1M | · | · | |
| Net Stock Activity | · | · | $16M | $1M | · | · | |
| Financing Cash Flow | $32M | $16M | $16M | $6.0K | $26M | $1M | |
| Net Change in Cash | $12M | $3M | $-2M | $-16M | $20M | $623.5K | |
| Free Cash Flow | · | · | $-18M | $-16M | $-6M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | · | · | -290.7% | -115.1% | -57.0% | · | |
| ROE | · | · | -610.0% | -305.9% | -31.4% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 1.3 | 1.7 | 9.0 | · | |
| Quick Ratio | · | · | 0.8 | 1.1 | 8.2 | · | |
| Interest Coverage | · | · | -347.4 | · | -64.7 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | $2.62 | $0.25 | $1.58 | · | |
| Cash Flow / Share | · | · | $-100.97 | $-1.21 | $-0.63 | · | |
| Cash / Share | · | · | $4.41 | $0.38 | $1.61 | · | |
| EPS (TTM) | $-52.59 | $-1336.63 | $-3419.01 | $-1082.79 | $-0.81 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-35M | $-17M | $-19M | $-18M | $-7M | · | |
| Market Cap | · | · | $3.83B | $6.46T | $24.23T | · | |
| P/E | -0.1 | -0.1 | -1.8 | -459.4 | -2317985.2 | · | |
| P/B | · | · | 2332.0 | 1992144.6 | 1187453.7 | · | |
| P / Tangible Book | · | · | 2332.0 | 1992144.6 | 1187453.7 | · | |
| P / Cash Flow | · | · | -211.7 | -409575.3 | -4600293.2 | · | |
| P / FCF | · | · | -211.3 | -406969.7 | -4387995.2 | · | |
| Earnings Yield | -770.0% | -1416.5% | -56.1% | -0.22% | 0.00% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $4M | $5M | $5M | $3M | $3M | $2M | $4M | $1M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| SG&A Expense | $3M | $2M | $2M | $1M | $2M | $951.7K | $1M | $938.0K | $2M | $2M | $734.0K | $2M | $2M | $2M | $3M | $2M | |
| Operating Expenses | $7M | $18M | $16M | $5M | $4M | $3M | $5M | $2M | $5M | $3M | $4M | $5M | $5M | $5M | $5M | $5M | |
| Operating Income | $-7M | $-18M | $-16M | $-5M | $-4M | $-3M | $-5M | $-2M | $-5M | $-3M | $-4M | $-5M | $-5M | $-5M | $-5M | $-5M | |
| Interest Expense | · | · | · | · | · | $114 | · | $10.8K | $4.5K | $9.7K | $17.3K | $17.3K | $7.8K | $13.4K | · | · | |
| Interest Income | $52.2K | $91.9K | $78.8K | $147 | $148 | $146 | $159 | $179 | $178 | $168 | $138 | $131 | $246 | $4.8K | $9.6K | $9.0K | |
| Other Non-op | $39.7K | $201.3K | $3M | $-294.9K | $-55.4K | $-9M | $-823.6K | $-156.0K | $-76.9K | $-37.8K | $10.0K | $10.3K | $781.3K | $70.8K | $361.4K | $664.0K | |
| Pretax Income | $-7M | $-18M | · | · | $-4M | $-12M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | · | · | $226.1K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-7M | $-18M | $-13M | $-5M | $-4M | $-12M | $-6M | $-2M | $-5M | $-3M | $-4M | $-5M | $-4M | $-5M | $-5M | $-4M | |
| EPS (Basic) | $-7.17 | $-21.28 | $-39.13 | $-5.82 | $-5.13 | $-70.16 | $-488.99 | $-146.06 | $-680.23 | $-21.35 | $-2969.12 | $-48.44 | $-142.38 | $-259.07 | $-1068.71 | $-6.61 | |
| EPS (Diluted) | $-7.17 | $-21.28 | $-39.13 | $-5.82 | $-5.13 | $-70.16 | $-488.99 | $-146.06 | $-680.23 | $-21.35 | $-2969.12 | $-48.44 | $-142.38 | $-259.07 | $-1068.71 | $-6.61 | |
| Shares (Basic) | 957,191 | 916,968 | · | 833,683 | 833,653 | 172,262 | · | 15,893 | 7,631 | 155,831 | · | 109,413 | 30,494 | 18,593 | · | 648,862 | |
| Shares (Diluted) | 957,191 | 916,968 | · | 833,683 | 833,653 | 172,262 | · | 15,893 | 7,631 | 155,831 | · | 109,413 | 30,494 | 18,593 | · | 648,862 | |
| EBITDA | · | $-18M | · | $-5M | $-4M | $-3M | · | $-2M | $-5M | $-3M | · | $-5M | $-5M | $-5M | · | $-5M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $13M | $18M | $3M | $7M | $12M | $6M | $2M | $3M | $5M | $3M | $7M | $4M | $2M | $5M | $9M | |
| Prepaid Expense | $2M | $2M | $919.4K | $2M | $690.8K | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $1M | $3M | $2M | $2M | |
| Current Assets | $11M | $17M | $22M | $5M | $8M | $13M | $7M | $4M | $4M | $7M | $4M | $9M | $5M | $4M | $7M | $12M | |
| PP&E (Net) | $322.8K | $346.7K | $370.7K | $19.9K | $24.7K | $38.1K | $51.6K | $61.4K | $64.6K | $92.4K | $120.7K | $152.4K | $179.0K | $191.8K | $208.6K | $209.9K | |
| PP&E (Gross) | $757.9K | $757.9K | $757.9K | $362.4K | $362.4K | $362.4K | $362.4K | $405.3K | $392.4K | $387.9K | $384.1K | $384.1K | $379.4K | $361.3K | $348.4K | $320.2K | |
| Accum. Depreciation | $435.1K | $411.2K | $387.3K | $342.5K | $337.7K | $324.3K | $310.8K | $343.9K | $327.9K | $295.5K | $263.3K | $231.7K | $200.5K | $169.5K | $139.9K | $110.4K | |
| Goodwill | $26M | $26M | $26M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $114M | $114M | $114M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $151M | $157M | $162M | $5M | $8M | $13M | $7M | $4M | $5M | $7M | $5M | $10M | $6M | $6M | $8M | $12M | |
| Accounts Payable | $5M | $5M | $3M | $3M | $2M | $3M | $3M | $2M | $3M | $2M | $3M | $5M | $3M | $5M | $4M | $4M | |
| Current Liabilities | $5M | $5M | $3M | $3M | $2M | $3M | $3M | $2M | $4M | $3M | $3M | $6M | $4M | $5M | $4M | $4M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $38.3K | $189.8K | $265.7K | $377.8K | · | · | |
| Deferred Tax | $457.7K | $457.4K | $226.1K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $13M | $13M | $11M | $4M | $2M | $3M | $9M | $2M | $4M | $3M | $4M | $6M | $4M | $6M | $4M | $4M | |
| Common Stock | $101 | $92 | $92 | $84 | $84 | $2.3K | $4 | $1.7K | $727 | $581 | $2 | $1.1K | $195 | $1.6K | $2 | $1.3K | |
| Paid-in Capital | $95M | $117M | $108M | $86M | $86M | $86M | $61M | $59M | $56M | $54M | $48M | $47M | $39M | $32M | $31M | $31M | |
| Retained Earnings | $-122M | $-116M | $-98M | $-84M | $-80M | $-75M | $-63M | $-57M | $-55M | $-50M | $-46M | $-42M | $-37M | $-33M | $-28M | $-23M | |
| Stockholders' Equity | $-28M | $1M | $10M | $1M | $6M | $10M | $-2M | $2M | $1M | $5M | $2M | $4M | $2M | $-236.8K | $3M | $8M | |
| Liabilities + Equity | $151M | $157M | $162M | $5M | $8M | $13M | $7M | $4M | $5M | $7M | $5M | $10M | $6M | $6M | $8M | $12M | |
| Shares Outstanding | 1,011,595 | 916,968 | 916,968 | 833,683 | 833,683 | 23,341,336 | 36,753 | 17,265,658 | 7,265,658 | 5,808,053 | 19,014 | 10,687,724 | 1,950,674 | 15,823,534 | 16,222 | 12,977,234 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $23.9K | $23.9K | $44.8K | $4.8K | $13.4K | $13.4K | $10.3K | $16.0K | $32.4K | $32.2K | $31.7K | $31.2K | $31.0K | $29.6K | $29.5K | $24.8K | |
| Stock-based Comp | · | · | $61.9K | $134.3K | $131.5K | $157.7K | $168.8K | $204.5K | $1M | $183.2K | $310.3K | $392.3K | $175.5K | $158.8K | $130.6K | $105.6K | |
| Deferred Tax | $300 | $231.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $13M | · | · | · | $9M | · | · | · | $-825.7K | · | · | · | $115.0K | · | · | |
| Operating Cash Flow | $-5M | $-5M | $-8M | $-4M | $-4M | $-3M | $-3M | $-4M | $-2M | $-4M | $-6M | $-4M | $-4M | $-5M | $-4M | $-4M | |
| CapEx | · | · | · | · | · | · | $500 | $12.9K | $4.6K | $3.8K | $0 | $4.6K | $18.1K | $12.9K | $28.2K | $0 | |
| Investing Cash Flow | · | · | · | · | · | · | $-500 | $-12.9K | $-4.6K | $-3.8K | $0 | $-4.6K | $-18.1K | $-12.9K | $-28.2K | $0 | |
| Stock Issued | · | · | $1 | $0 | $0 | $9M | $7M | $2M | $785.2K | $6M | $978.2K | $7M | $6M | $1M | · | · | |
| Net Stock Activity | · | · | · | · | · | $9M | · | · | · | $6M | · | · | · | $1M | · | · | |
| Financing Cash Flow | · | · | $23M | $-455.7K | $0 | $9M | $7M | $2M | $785.2K | $6M | $978.2K | $7M | $6M | $1M | $225.8K | $-225.8K | |
| Net Change in Cash | $-4M | $-5M | $15M | $-5M | $-4M | $6M | $4M | $-1M | $-2M | $2M | $-5M | $4M | $2M | $-3M | $-4M | $-5M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-4M | · | · | · | $-5M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -20.9% | · | -106.0% | -65.3% | -128.7% | · | -41.4% | -97.0% | · | · | -47.6% | -43.3% | -39.4% | · | -22.9% | |
| ROE | · | -308.1% | · | -315.5% | -114.5% | -240.4% | · | -74.5% | -304.0% | · | · | -83.6% | -59.8% | -57.5% | · | -27.3% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 3.1 | · | 1.6 | 5.3 | 5.2 | · | 1.6 | 1.3 | · | · | 1.7 | 1.4 | 0.8 | · | 3.1 | |
| Quick Ratio | · | 2.4 | · | 1.0 | 4.7 | 4.6 | · | 0.8 | 1.0 | · | · | 1.3 | 1.0 | 0.3 | · | 2.3 | |
| Interest Coverage | · | · | · | · | · | -27817.4 | · | -200.6 | -1141.0 | -338.9 | · | · | · | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $1.36 | · | $1.71 | $7.37 | $0.44 | · | $0.10 | $0.18 | · | · | $0.42 | $1.07 | $-0.01 | · | $0.64 | |
| Cash Flow / Share | · | $-5.43 | · | · | · | $-0.64 | · | · | · | $-0.77 | · | · | · | $-0.31 | · | · | |
| Cash / Share | · | $14.00 | · | $3.40 | $8.85 | $0.50 | · | $0.11 | $0.46 | · | · | $0.70 | $1.83 | $0.10 | · | $0.68 | |
| EPS (TTM) | $-73.40 | $-71.36 | · | $-570.10 | $-710.34 | $-1385.44 | · | $-3816.76 | $-3719.14 | $-3181.29 | · | $-1518.60 | $-1476.77 | $-1341.59 | · | $-14.23 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-43M | $-40M | · | $-27M | $-25M | $-26M | · | $-15M | $-18M | $-17M | · | $-20M | $-19M | $-19M | · | $-15M | |
| Market Cap | $6M | $8M | · | $9M | $7M | $324M | · | $9.11B | $6.75B | · | · | $198.69B | $165.82B | $3.97T | · | $10.55T | |
| P/E | -0.1 | -0.1 | · | -0.0 | -0.0 | -0.0 | · | -0.1 | -0.2 | -0.2 | · | -12.2 | -57.6 | -186.8 | · | -57141.3 | |
| P/B | -0.2 | 6.3 | · | 6.3 | 1.1 | 31.4 | · | 5513.6 | 5102.6 | · | · | 44752.0 | 79247.7 | -16745499.6 | · | 1279936.5 | |
| P / Tangible Book | · | · | · | 6.3 | 1.1 | 31.4 | · | 5513.6 | 5102.6 | · | · | 44752.0 | 79247.7 | · | · | 1279936.5 | |
| P / Cash Flow | · | -1.6 | · | · | · | -104.5 | · | · | · | · | · | · | · | -878510.1 | · | · | |
| Earnings Yield | -1182.0% | -828.8% | · | -5303.3% | -9106.9% | -9996.0% | · | -723.4% | -400.5% | -504.1% | · | -8.2% | -1.7% | -0.54% | · | 0.00% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-35M | $-17M | $-19M | $-18M | $-7M |
| EPS Dilusian | $-52.59 | $-1336.63 | $-3419.01 | $-1082.79 | $-0.81 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | · | · | 1.3 | 1.7 | 9.0 |
| Rasio Cepat | · | · | 0.8 | 1.1 | 8.2 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | · | · | $-18M | $-16M | $-6M |
Pemilik institusional (13F) 8 pengaju · $208K total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
8
Nilai yang dipegang
$208K
Posisi baru
2
Posisi yang keluar
2
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 2 (-2 vs Kuartal sebelumnya) | 2 (0 vs Kuartal sebelumnya) | 1 (-1 vs Kuartal sebelumnya) | 1 (0 vs Kuartal sebelumnya) | +3K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Yorkville Advisors Global, LP | $121.958 | 19.639 | 58,62% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $40.644 | 6.545 | 19,53% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $18.518 | 2.982 | 8,90% | Saham |
| UBS Group AG | $17.934 | 2.888 | 8,62% | Saham |
| FMR LLC | $4.384 | 706 | 2,11% | Saham |
| Tower Research Capital LLC (TRC) | $4.204 | 677 | 2,02% | Saham |
| WELLS FARGO & COMPANY/MN | $342 | 55 | 0,16% | Saham |
| SBI Securities Co., Ltd. | $75 | 12 | 0,04% | Saham |
Aktivis & pemilik 5%+ 5 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| DEFJ, LLC, CK Life Sciences Int'l., (Holdings) Inc. ×4 pengajuan | 3 Agu 2026 | 83,90% | Amandemen | · | SEC |
| CK Life Sciences Int'l., (Holdings) Inc., DEFJ, LLC ×2 pengajuan | 28 Okt. 2025 | 9,10% | Amandemen | · | SEC |
| Thomas Joseph Tracy | 20 Maret 2025 | 5,00% | Pengajuan awal | Investasi pasif | SEC |
| Thomas A. Fitzgerald (2) | 21 Juni 2024 | · | Pengajuan awal | · | SEC |
| Robert Michael Dudley (2) ×3 pengajuan | 10 Okt. 2023 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 6 orang dalam · 3 pejabat · 5 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Robert Michael Dudley | Chief Executive Officer | 28 Sep. 2023 P | 180.262 | 0 | 0 | $0 |
| Thomas A Fitzgerald | Chief Financial Officer | 9 Sep. 2026 A | 56.318 | 0 | 0 | $0 |
| Zdravka Medarova | Chief Technology Officer | 12 Des. 2022 A | · | 0 | 0 | $0 |
| Erik Manting | Direktur | 14 Juni 2024 A | · | 0 | 0 | $0 |
| Philippe Calais | Direktur | 14 Juni 2024 A | · | 0 | 0 | $0 |
| Magda Marquet | Direktur | 14 Juni 2024 A | · | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 1 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 6.545 SH | 19 Agu 2026 | Harian |
RNAZ Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 7 analis
BELI
2 28,6%
Beli Kuat
4 57,1%
Beli
1 14,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| RNAZ | · | -0.1 | · | · | · | · |
| ATYR | $77M | -1.0 | -19.1% | -39009.5% | -107.8% | · |
| SHPH | $4M | -0.3 | 0.00% | · | -400.1% | · |
| GRDX | $20M | -1.1 | · | -17634.4% | -68.6% | -1813.6% |
| KYNB | $36M | 0.2 | -78.3% | 2848.6% | -143.5% | · |
| NXTC | $50M | -0.7 | · | · | -172.9% | · |
| ATOS | $5M | -0.1 | · | · | -71.7% | · |
| TCRX | · | -1.0 | 266.7% | -1256.8% | -86.6% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 14, 2026